Patient characteristics
| Characteristic . | Quantity . |
|---|---|
| Patients, no. | 89 |
| Male/female | 45/44 |
| Age at diagnosis, y, mean (range) | 55 (16-79) |
| WBC count at diagnosis,109/L, mean (range) | 38 (0.7-278) |
| FAB classification, no. (%) | |
| M0 | 5 (6) |
| M1 | 12 (13) |
| M2 | 14 (16) |
| M3 | 3 (3) |
| M4 | 11 (12) |
| M5 | 20 (23) |
| M6 | 3 (3) |
| Refractory anemia with excess blasts | 10 (11) |
| Refractory anemia with excess blasts in transformation | 5 (6) |
| Not classified | 6 (7) |
| Cytogenetic risk group, no. (%) | |
| Favorable | 11 (12) |
| Intermediate | 49 (55) |
| Poor | 9 (10) |
| No metaphases | 20 (23) |
| Flt3 ITD, no. (%) | |
| Present | 22 (25) |
| Absent | 54 (61) |
| Not analyzed | 13 (14) |
| Characteristic . | Quantity . |
|---|---|
| Patients, no. | 89 |
| Male/female | 45/44 |
| Age at diagnosis, y, mean (range) | 55 (16-79) |
| WBC count at diagnosis,109/L, mean (range) | 38 (0.7-278) |
| FAB classification, no. (%) | |
| M0 | 5 (6) |
| M1 | 12 (13) |
| M2 | 14 (16) |
| M3 | 3 (3) |
| M4 | 11 (12) |
| M5 | 20 (23) |
| M6 | 3 (3) |
| Refractory anemia with excess blasts | 10 (11) |
| Refractory anemia with excess blasts in transformation | 5 (6) |
| Not classified | 6 (7) |
| Cytogenetic risk group, no. (%) | |
| Favorable | 11 (12) |
| Intermediate | 49 (55) |
| Poor | 9 (10) |
| No metaphases | 20 (23) |
| Flt3 ITD, no. (%) | |
| Present | 22 (25) |
| Absent | 54 (61) |
| Not analyzed | 13 (14) |
WBC indicates white blood cell; FAB, French-American-British.